Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The Salmonella enterica Paratyphi A O:2 antigen is a serovar-specific O-antigen polysaccharide forming the outermost component of LPS (lipopolysaccharide) on the surface of Salmonella Paratyphi A, a Gram-negative bacterium responsible for paratyphoid fever[2][5]. The O:2 antigen consists of a trisaccharide backbone—rhamnose, mannose, and galactose—with serospecific branches of paratose and glucose, and partial O-acetylation, distinguishing it from other Salmonella O antigens[1][3][5]. This antigen is immunodominant, induces strong host antibody responses, and acts as a primary protective antigen being investigated for inclusion in conjugate vaccines to prevent Paratyphi A infections[1][3][4]. Experimental vaccine strategies utilize detoxified and highly purified O:2 polysaccharide in conjugation with carrier proteins or incorporate it into bacterial outer membrane vesicles to induce potent, functional immune protection. The O:2 antigen is also a determinant of serovar identity and plays roles in immune evasion and as a receptor for certain bacteriophages[2][5]. Deletion or mutation leads to bacterial death, highlighting its importance for bacterial viability and pathogenicity[2].
Induction of antibody-mediated immunity (vaccination elicits antibodies against O:2 antigen conferring protection)[1][3][4][5]; Passive protection via serum bactericidal activity
1 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Salmonella enterica Paratyphi A O:2 antigen.